Intelligence · Clinical Development
Pipeline search results
Programs matching “rheumatoid-arthritis” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 82 pipeline programs matching "rheumatoid-arthritis" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
CF101 1 mg
Can-Fite BioPharma
Rheumatoid Arthritis
1 trial -
CHS-0214
Coherus Oncology
Rheumatoid Arthritis
1 trial -
Etanercept
Coherus Oncology
Rheumatoid Arthritis
1 trial -
Etanercept
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Rheumatoid Arthritis
1 trial -
Infliximab Increased Frequency
Universal Integrated
Rheumatoid Arthritis
1 trial -
LY2127399
Eli Lilly and Company
Rheumatoid Arthritis
1 trial -
Olokizumab
International Peace Maternity and Child Health Hospital
Rheumatoid Arthritis
1 trial -
Olokizumab 64 mg SC q4w
International Peace Maternity and Child Health Hospital
Rheumatoid Arthritis
1 trial -
Olokizumab 64mg q4w
International Peace Maternity and Child Health Hospital
Rheumatoid Arthritis
1 trial -
PF-06438179
Pfizer
Rheumatoid Arthritis
1 trial -
Peficitinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Rheumatoid Arthritis (RA)
1 trial -
Placebo
AbbVie
Rheumatoid Arthritis
1 trial -
Placebo for Adalimumab
AbbVie
Rheumatoid Arthritis
1 trial -
Placebo injections
Centocor B.V.
Rheumatoid Arthritis
1 trial -
Placebo to Upadacitinib
AbbVie
Rheumatoid Arthritis
1 trial -
SAR153191 (REGN88)
Regeneron UK Limited
Rheumatoid Arthritis
2 trials -
Sarilumab
Sanofi Pasteur
Rheumatoid Arthritis
1 trial -
Tocilizumab 162 mg
Hoffmann-La Roche
Rheumatoid Arthritis
1 trial -
VX-509
Vertex Pharmaceuticals (Australia) Pty.
Rheumatoid Arthritis
3 trials -
sarilumab SAR153191 (REGN88)
Regeneron UK Limited
Rheumatoid Arthritis
6 trials -
tocilizumab [RoActemra/Actemra]
Hoffmann-La Roche
Rheumatoid Arthritis
3 trials -
ASP5094
Astellas Pharma Inc
Rheumatoid Arthritis (RA)
1 trial -
ATI-450
Aclaris Therapeutics
Rheumatoid Arthritis
1 trial -
ATI-450 50 mg oral tablet BID
Aclaris Therapeutics
Rheumatoid Arthritis
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.